This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Buck, J. M. Search for Related Content PubMed Articles by Buck, J. M. Social Bookmarking                         What's this?

Hepatitis B Vaccination in Prison: The Perspectives of Formerly Incarcerated Men

Pritzker School of Medicine, University of Chicago, Illinois

Kathleen M. Morrow, PhD

Centers for Behavioral and Preventive Medicine, The Miriam Hospital and Brown Medical School, Providence, Rhode Island

Andrew Margolis, MPH

Centers for Disease Control and Prevention, Atlanta, Georgia

Gloria Eldridge, PhD

University of Alaska, Anchorage

James Sosman, MD

Department of Medicine, University of Wisconsin Medical School, Madison

Robin MacGowan, MPH

Centers for Disease Control and Prevention, Atlanta, Georgia

Diane Binson, PhD

University of California, San Francisco-CAPS

Deborah Kacanek, ScD

Tufts-New England Medical Center, Boston, Massachusetts

Timothy P. Flanigan, MD

Department of Medicine, The Miriam Hospital and Brown Medical School, Providence, Rhode Island, tflanigan{at}lifespan.org

The Project START Study Group

Nearly 30% of new hepatitis B virus (HBV) infections have been detected in people with a history of incarceration. Although a safe and effective HBV vaccine is available, it is not routinely provided to inmates. This is a significant missed public health opportunity. Barriers to routine vaccination include cost, difficulties completing vaccination series in a transient population, insufficient collaboration between public health organizations and correctional health systems, and inmate refusal. This study assessed inmates’ knowledge, attitudes, and perceptions of HBV and of HBV testing and vaccination. Hepatitis B virus testing and vaccination were offered. Interviews were conducted with 42 men, aged 18 to 29 years, recently released from prison. Of the 28 men who agreed to be tested, 71% were susceptible to HBV. Many had misconceptions about HBV or HBV vaccination, but most were willing to be vaccinated once informed. Barriers to vaccination during incarceration were fear of needles and distrust of prison staff; after release, barriers were time and cost. These findings support the need for education and routine HBV vaccination programs for inmates during incarceration.

Key Words: hepatitis B • vaccine • correctional health • prison inmates

Journal of Correctional Health Care, Vol. 12, No. 1, 12-23 (2006)
DOI: 10.1177/1078345806287937


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?